Status:
UNKNOWN
To Assess and Compare the Performance Two Approach for Sentinel Lymph Node (SNLD) Biopsy for Endometrial Cancer
Lead Sponsor:
Haseki Training and Research Hospital
Conditions:
Endometrial Cancer
Sentinel Lymph Node
Eligibility:
FEMALE
18-90 years
Brief Summary
to assess and compare the performance two approaches for sentinel lymph node ( SLND) biopsy
Detailed Description
Endometrial cancer is the most common gynecologic cancer. Most patients diagnosed in early stages because cancer causes remarkable symptoms such as postmenopausal or abnormal bleeding. Mostly, it does...
Eligibility Criteria
Inclusion
- The patient must be willing and able to provide informed consent
- The patient is willing and able to comply with the study protocol
- The patient has endometrial cancer and is performed SLND
- The patient agrees to follow-up examination out to 5-years post-treatment
Exclusion
- The patient is not a candidate for surgery
- The patient has metastasis
- The patient has known or suspected allergies to iodine, indocyanine green( ICG)
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 30 2021
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT04514289
Start Date
March 1 2020
End Date
August 30 2021
Last Update
August 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cihan Comba
Istanbul, Sultangazi, Turkey (Türkiye), 34265